AI for drug development: Experts break down what’s possible — and what’s just hype
(By Kate Sheridan for STAT) If a group of chemists found 18 more potent versions of a drug out of
Read More(By Kate Sheridan for STAT) If a group of chemists found 18 more potent versions of a drug out of
Read MoreCMS updated Chapters 13 and 14 from the Part D Prescription Drug Benefit Manual (PDBM) which affects Part D plan
Read More(By Morgan Haefner for Becker’s Hospital Review) CVS Health entered into an agreement with the Department of Justice to move
Read More(By Susan Jaffe for Kaiser Health News) For years, most pharmacists couldn’t give customers even a clue about an easy
Read More(By Jake Harper, Side Effects Public Media, produced in partnership with NPR and Kaiser Health News) Months in prison didn’t
Read More(By Melissa Bailey for Kaiser Health News) Hospice workers would be allowed to destroy patients’ unneeded opioids, reducing the risk
Read MoreDuring Medicare Open Enrollment you have the opportunity to make changes to your health and prescription drug coverage. Any changes
Read MoreOn Wednesday, the Senate passed a bipartisan bill aimed at fighting the opioid crisis. The 660-page bill includes a range
Read More(By Nicholas Florko for STAT) WASHINGTON — It’s less than a week old, but a shadowy new pharma advocacy group
Read More(By Kelly Gooch for Becker’s Hospital Review) The CEOs of more than 700 hospitals and health systems penned a letter to U.S.
Read More